• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带电荷和不带电荷的表面活性剂对 Alpha-突触核蛋白纤维聚集的(去)稳定作用。

(De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants.

机构信息

LEPABE, Department of Chemical Engineering, Faculty of Engineering of the University of Porto, 4200-465 Porto, Portugal.

Faculty of Pharmaceutical Sciences, Ghent University, Sint-Pietersnieuwstraat 25, B-9000 Ghent, Belgium.

出版信息

Int J Mol Sci. 2021 Nov 19;22(22):12509. doi: 10.3390/ijms222212509.

DOI:10.3390/ijms222212509
PMID:34830391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8624236/
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder. An important hallmark of PD involves the pathological aggregation of proteins in structures known as Lewy bodies. The major component of these proteinaceous inclusions is alpha (α)-synuclein. In different conditions, α-synuclein can assume conformations rich in either α-helix or β-sheets. The mechanisms of α-synuclein misfolding, aggregation, and fibrillation remain unknown, but it is thought that β-sheet conformation of α-synuclein is responsible for its associated toxic mechanisms. To gain fundamental insights into the process of α-synuclein misfolding and aggregation, the secondary structure of this protein in the presence of charged and non-charged surfactant solutions was characterized. The selected surfactants were (anionic) sodium dodecyl sulphate (SDS), (cationic) cetyltrimethylammonium chloride (CTAC), and (uncharged) octyl β-D-glucopyranoside (OG). The effect of surfactants in α-synuclein misfolding was assessed by ultra-structural analyses, in vitro aggregation assays, and secondary structure analyses. The α-synuclein aggregation in the presence of negatively charged SDS suggests that SDS-monomer complexes stimulate the aggregation process. A reduction in the electrostatic repulsion between N- and C-terminal and in the hydrophobic interactions between the NAC (non-amyloid beta component) region and the C-terminal seems to be important to undergo aggregation. Fourier transform infrared spectroscopy (FTIR) measurements show that β-sheet structures comprise the assembly of the fibrils.

摘要

帕金森病(PD)是第二常见的神经退行性疾病。PD 的一个重要标志涉及到称为路易体的结构中蛋白质的病理性聚集。这些蛋白包涵体的主要成分是α(α)-突触核蛋白。在不同的条件下,α-突触核蛋白可以呈现富含α-螺旋或β-折叠的构象。α-突触核蛋白错误折叠、聚集和纤维化的机制尚不清楚,但人们认为α-突触核蛋白的β-折叠构象与其相关的毒性机制有关。为了深入了解α-突触核蛋白错误折叠和聚集的过程,研究了在带电荷和不带电荷的表面活性剂溶液中该蛋白质的二级结构。选择的表面活性剂为(阴离子)十二烷基硫酸钠(SDS)、(阳离子)十六烷基三甲基氯化铵(CTAC)和(非离子)辛基-β-D-吡喃葡萄糖苷(OG)。通过超微结构分析、体外聚集测定和二级结构分析评估了表面活性剂对α-突触核蛋白错误折叠的影响。带负电荷的 SDS 存在下的α-突触核蛋白聚集表明 SDS-单体复合物刺激了聚集过程。似乎重要的是,N-和 C-末端之间的静电排斥减少以及 NAC(非淀粉样β成分)区域和 C-末端之间的疏水性相互作用减少,以进行聚集。傅里叶变换红外光谱(FTIR)测量表明β-折叠结构构成了纤维的组装。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/2db88af46ee1/ijms-22-12509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/749fd921ce14/ijms-22-12509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/ad6ff8d51aef/ijms-22-12509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/5cf88ae994f5/ijms-22-12509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/6ab1553da7c8/ijms-22-12509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/2db88af46ee1/ijms-22-12509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/749fd921ce14/ijms-22-12509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/ad6ff8d51aef/ijms-22-12509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/5cf88ae994f5/ijms-22-12509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/6ab1553da7c8/ijms-22-12509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/8624236/2db88af46ee1/ijms-22-12509-g005.jpg

相似文献

1
(De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants.带电荷和不带电荷的表面活性剂对 Alpha-突触核蛋白纤维聚集的(去)稳定作用。
Int J Mol Sci. 2021 Nov 19;22(22):12509. doi: 10.3390/ijms222212509.
2
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.小分子抑制α-突触核蛋白聚集,破坏淀粉样纤维,防止多巴胺能神经元变性。
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10481-10486. doi: 10.1073/pnas.1804198115. Epub 2018 Sep 24.
3
Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.在3,4-二羟基苯乙酸存在下生长的α-突触核蛋白寡聚体的结构特征与毒性
Int J Mol Sci. 2021 Jun 2;22(11):6008. doi: 10.3390/ijms22116008.
4
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.由α-突触核蛋白以及与帕金森病相关的两种突变形式在体外形成的原纤维是典型的淀粉样蛋白。
Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r.
5
Covalent α-synuclein dimers: chemico-physical and aggregation properties.共价α-突触核蛋白二聚体:化学物理和聚集性质。
PLoS One. 2012;7(12):e50027. doi: 10.1371/journal.pone.0050027. Epub 2012 Dec 13.
6
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.小分子α-突触核蛋白错误折叠抑制剂 NPT200-11 在帕金森病动物模型中产生多种益处。
Sci Rep. 2018 Nov 1;8(1):16165. doi: 10.1038/s41598-018-34490-9.
7
Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.与家族性帕金森病相关的突变会改变α-突触核蛋白聚集的起始和扩增步骤。
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10328-33. doi: 10.1073/pnas.1604645113. Epub 2016 Aug 29.
8
Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties.酪氨酸突变为丙氨酸对α-突触核蛋白纤维化及结构特性的影响。
Biochim Biophys Acta. 2008 Oct;1782(10):581-5. doi: 10.1016/j.bbadis.2008.07.004. Epub 2008 Jul 22.
9
Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy.二维红外光谱和原子力显微镜联用研究α-突触核蛋白纤维中的分子内反平行β-折叠结构证据。
Sci Rep. 2017 Jan 23;7:41051. doi: 10.1038/srep41051.
10
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.新发现的与帕金森病相关的突变G51D可减弱α-突触核蛋白在体外的聚集和膜结合,并增强其在细胞中的分泌和核定位。
Hum Mol Genet. 2014 Sep 1;23(17):4491-509. doi: 10.1093/hmg/ddu165. Epub 2014 Apr 11.

引用本文的文献

1
Targeting the glymphatic system to promote α-synuclein clearance: a novel therapeutic strategy for Parkinson's disease.靶向类淋巴系统促进α-突触核蛋白清除:帕金森病的一种新治疗策略。
Neural Regen Res. 2025 Jan 13;21(1):233-47. doi: 10.4103/NRR.NRR-D-24-00764.
2
Advancing Parkinson's diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples.推进帕金森病诊断:用于在微创样本中检测α-突触核蛋白的种子扩增检测法。
Mol Cell Biochem. 2025 Jun;480(6):3297-3314. doi: 10.1007/s11010-024-05190-y. Epub 2025 Jan 6.
3
Conformational Selection of α-Synuclein Tetramers at Biological Interfaces.

本文引用的文献

1
Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine.析因设计作为优化用于替莫唑胺和O6-苄基鸟嘌呤共递送的聚乳酸-羟基乙酸共聚物纳米颗粒的工具
Pharmaceutics. 2019 Aug 10;11(8):401. doi: 10.3390/pharmaceutics11080401.
2
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.α-突触核蛋白:从早期突触功能障碍到神经退行性变
Front Neurol. 2018 May 4;9:295. doi: 10.3389/fneur.2018.00295. eCollection 2018.
3
Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T.
α-突触核蛋白四聚体在生物界面的构象选择。
J Chem Inf Model. 2024 Oct 28;64(20):8010-8023. doi: 10.1021/acs.jcim.4c01459. Epub 2024 Oct 8.
小分子硫黄素T对α-突触核蛋白原纤维中结构异质性程度的调节作用
J Biol Chem. 2017 Oct 13;292(41):16891-16903. doi: 10.1074/jbc.M117.795617. Epub 2017 Jul 31.
4
Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.用于治疗阿尔茨海默病的白藜芦醇和葡萄提取物负载型固体脂质纳米粒
Molecules. 2017 Feb 13;22(2):277. doi: 10.3390/molecules22020277.
5
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.通过检测脑脊液中α-突触核蛋白错误折叠聚集体开发帕金森病的生化诊断方法。
JAMA Neurol. 2017 Feb 1;74(2):163-172. doi: 10.1001/jamaneurol.2016.4547.
6
Inhibition effects of tanshinone on the aggregation of α-synuclein.丹参酮对α-突触核蛋白聚集的抑制作用。
Food Funct. 2016 Jan;7(1):409-16. doi: 10.1039/c5fo00664c.
7
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease.能够解释帕金森病进展和不可逆转性的α-突触核蛋白的特征。
Front Neurosci. 2015 Mar 9;9:59. doi: 10.3389/fnins.2015.00059. eCollection 2015.
8
Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).稳态和时间分辨的硫黄素-T荧光可以反映由Aβ(1-40)和Aβ(1-42)形成的淀粉样纤维的形态差异。
Biochem Biophys Res Commun. 2015 Mar 6;458(2):418-23. doi: 10.1016/j.bbrc.2015.01.132. Epub 2015 Feb 7.
9
Adsorption of β-amyloid oligomers on octadecanethiol monolayers.β-淀粉样寡聚体在十八烷硫醇单分子层上的吸附
J Colloid Interface Sci. 2014 Jul 1;425:159-67. doi: 10.1016/j.jcis.2014.03.042. Epub 2014 Mar 25.
10
N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes.N-端乙酰化稳定了脂结合和胶束结合的α-突触核蛋白中 N-端的螺旋结构,并增加了其与生理膜的亲和力。
J Biol Chem. 2014 Feb 7;289(6):3652-65. doi: 10.1074/jbc.M113.512459. Epub 2013 Dec 12.